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MicroRNAs (miRNAs) are found in most metazoan organisms as well as in viruses and are implicated
in an increasingly wide variety of biological processes in animals. Here, Taganov et al. discuss the role
of miRNAs in the innate immune response to microbial infection.Introduction
RNA-mediated gene silencing is used
by most eukaryotic organisms to
modulate expression of protein-cod-
ing genes, to fight invading viruses,
and to quell the spread in the genome
of ‘‘parasitic’’ genetic mobile elements
such as transposons. RNA silencing
relies on a sequence-specific interac-
tion between the target RNA (or DNA
in certain cases) molecule and a small
RNA incorporated into the multi-
subunit RNA-induced silencing (RISC)
complex. Several classes of small
silencing RNAs have been identified
thus far includingmicroRNAs (miRNAs),
small interfering RNAs (siRNAs), Piwi-
interacting RNAs (piRNAs), transacting
siRNAs (tasiRNAs), etc. They differ in
length (18–30 bp) and origin but share
a common set of proteins required for
their function and sometimes produc-
tion. This commentary will focus ex-
clusively on the role in immunity of
miRNAs, an evolutionarily conserved
and abundant class of small silencing
RNAs.
miRNAs: Biogenesis, Regulation
of Expression, and Molecular
Targets
Functional miRNAs are excised from
long endogenous transcripts by the
sequential action of a pair of endonu-
cleases (Drosha and Dicer) that reside
in different compartments in the cell
(see Figure 1). In the nucleus, the pri-
mary microRNA (pri-miRNA) transcript
is first cleaved by Drosha, liberating
an approximately 60-to-80-nucleotide-
long hairpin-shaped precursor miRNA
(pre-miRNA). This pre-miRNA is then
exported from the nucleus to the cyto-plasm, where it undergoes a further
round of processing by the Dicer en-
zyme and the resulting 22 nucleotide
RNA is then loaded onto the RISC
complex. Perfect base pairing be-
tween the RISC-bound miRNA and
the target mRNA results in cleavage
and degradation of the latter, whereas
imperfect complementarity generally
leads to translational repression of
the target.
Primary microRNAs transcripts, like
protein-coding mRNAs, are generally
synthesized by RNA polymerase II,
and therefore their expression is sub-
ject to the exquisite regulation pro-
vided by the assortment of transcrip-
tional factors in the cell. Although
some miRNAS are widely expressed,
others are only expressed in limited
developmental stages or in specific
tissues or cells. Several recent reports
suggest that amounts of mature
miRNAs in the cell can be also con-
trolled posttranscriptionally at the level
of processing by Drosha or Dicer. For
example, several pri-miRNA tran-
scripts, including those of the let-7
family, are highly expressed during
early mouse development, whereas
no corresponding pre-miRNAs or ma-
ture miRNAs are detected until ap-
proximately day 10.5 of gestation;
these findings indicate some type of
modulation of Drosha activity in the
embryo (Thomson et al., 2006). Regu-
lation at the Dicer processing step
has also been observed (Ambros
et al., 2003; Obernosterer et al., 2006).
There are currently 474 human
miRNA sequences listed in the miRNA
registry (release 9.0, October 2006
[Griffiths-Jones, 2004]), but the totalImmunity 26number of miRNA genes according to
some computer-assisted estimates
might be closer to a thousand (or
even higher) and thus potentially con-
stitutes 3% of the human genome
(Bentwich et al., 2005; Berezikov
et al., 2005; Miranda et al., 2006). The
number of predicted conservedmRNA
targets per mammalian miRNA is
estimated to be roughly 200 on aver-
age, suggesting that expression of
10,000 genes or 30% of the human
genome can be regulated by miRNAs
(Lewis et al., 2005). The number of tar-
get genes for particular miRNAs may
be substantially increased if sequence
alterations due to A-to-I RNA editing of
miRNA sequences (Blow et al., 2006)
and potential evolutionarily noncon-
served target sites are factored in.
Given the difficulty of defining the
real, in vivo targets for animal miRNAs,
it is not surprising to find that our
knowledge of the biological functions
of miRNAs is far from comprehensive.
The vital importance of RNA silencing
pathways during development has
been clearly demonstrated by tar-
geted deletions of genes involved in
different aspects of miRNA biogenesis
and function in a number of biological
models (Bernstein et al., 2003; Kanel-
lopoulou et al., 2005; Liu et al., 2004).
Role of miRNAs in the
Development of Hematopoietic
Cell Lineages and Cancer
The elevated tissue-specific expres-
sion of some miRNA genes suggests
that they might be involved in tissue
differentiation andmaintenanceof cell-
type identity in animals; miRNAswould
share such a role with tissue-specific, February 2007 ª2007 Elsevier Inc. 133
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CommentaryFigure 1. A Proposed Model of miR-146 Negative Feedback Regulation of TLR4 Signal Transduction Pathways
Triggering of TLR4 receptor by LPS activates downstream NF-kB signaling, leading to subsequent induction of immune-response genes, including
the gene for miR-146. miR-146 primary (pri-miR-146) transcript undergoes stepwise processing by two RNase III enzymes, Drosha and Dicer. The
mature miR-146 is then loaded onto the RISC complex and guides it to the target IRAK1 and TRAF6 mRNAs and thus brings about a reduction in their
expression and attenuation of TLR4 signaling.transcriptional factors. A number of
expression-profiling studies found
distinct patterns of miRNA expression
in different hematopoietic cell lineages
(Chen et al., 2004; Felli et al., 2005;
Garzon et al., 2006). For example,
miR-150 amounts are elevated during
developmental stages of B and T cell
maturation, although its expression is
rapidly decreased upon differentiation134 Immunity 26, February 2007 ª2007 Eof naive T cells into Th1 or Th2 sub-
types; in contrast, miR-146 expression
under the same conditions was differ-
entially upregulated in the Th1 subset
and abolished in Th2 cells (Monticelli
et al., 2005). Regulatory T (Treg) cells
were also shown to express a distinct
miRNA subset, which resembles a
profile of miRNAs expressed in acti-
vated but not naive T cells. Moreover,lsevier Inc.enforced expression of the Treg
signature transcriptional factor FoxP3
in conventional T cells can confer a
partial Treg-cell miRNA profile (Cobb
et al., 2006). The most direct evidence
so far for the ability of miRNAs to influ-
ence hematopoietic lineage commit-
ment and differentiation was devel-
oped with both ectopic expression of
candidate, lineage-specific miRNAs in
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lation of theDicer-1 gene inmice (Chen
et al., 2004; Cobb et al., 2005; Muljo
et al., 2005). T cell levels were variably
affected by particular manipulations
used in these studies.
Given the accumulating body of re-
search on the role of miRNAs in prolif-
eration and differentiation of hemato-
poietic cells, it is not surprising to find
that changes in miRNA expression
may contribute to cancer predisposi-
tion and progression in the cells of the
immune system and may serve as
a novel tumor prognostic marker. For
example, amajority of chronic lympho-
cytic leukemia cells are characterized
by deletion or misregulation of expres-
sion of the MIRN15A/MIRN16-1 gene
cluster (reviewed in [Calin and Croce,
2006]). Cimmino et al. reported that
these miRNAs promote apoptosis by
targeting Bcl2 expression and there-
fore act as ‘‘tumor suppressor’’ RNAs
(reviewed in [Calin and Croce, 2006]).
In contrast, high expression of ‘‘onco-
gene-like’’ miRNAs, particularly miR-
155 and those from the MIRN17-92
cluster, is characteristic of several
human cancers, including some lym-
phomas. Strikingly, transgenic mice
expressing mouse miR-155 in a B cell-
specific manner showed, in the spleen
and bone marrow, accelerated rates
of pre-B cell proliferation that resulted
in the development of a B cell lympho-
proliferative disorder by 6 months (re-
viewed in [Calin and Croce, 2006]).
miRNAs and Virus-Host
Interaction: In the Middle
of a Raging War
Although there is an ongoing debate
as to whether virus-derived siRNAs
(thought to arise from long double-
stranded RNAs through the biogenesis
pathway shared with miRNAs) have an
effect on antiviral immunity in verte-
brates (reviewed in [Cullen, 2006a]),
there is evidence that miRNAs of the
host may impinge on the viral life cycle,
viral tropism, and the pathogenesis of
viral diseases. For example, human
miR-32 has a direct negative effect
on the replication of retrovirus primate
foamy virus type 1 (PFV-1), which is
mediated through the downregulation
of replication-essential viral proteins
encoded by open reading frame 2(ORF2) (reviewed in [Cullen, 2006b]).
Intriguingly, in a typical ‘‘punch-coun-
terpunch’’ style of virus-host interac-
tion, PFV encodes a protein called
Tas, which appears to be a strong,
global suppressor of RNA silencing.
Many other viruses employ a similar
strategy to deal with the antiviral ef-
fects of RNAi but implement it in differ-
ent ways (reviewed in [Cullen, 2006b]).
Considering how adept viruses can
be at the ‘‘hijacking’’ of host genes, uti-
lizing them in their own counter-de-
fense measures, it is no surprise that
such small, but powerful ‘‘weapons’’
as host miRNAs have found their way
into the viral genomes. A growing list
of human viruses, including herpes
viruses, polyomaviruses, and retrovi-
ruses, have been shown to encode
miRNAs’ targetingexpressionofawide
range of cellular genes, among them
genes for cytokines and signaling
proteins (reviewed in [Cullen, 2006b]).
miRNAs and Regulation of Signal
Transduction in Immune Cells
Innate immunity is a phylogenetically
ancient biological system that multi-
cellular organisms have evolved to de-
fend themselves from invading patho-
gens. The job of recognition of the
‘‘nonself’’ from the ‘‘self’’ in this system
belongs to pattern recognition recep-
tors (PRRs). Acting as molecular senti-
nels, PRRs sense highly conserved
microbial molecules (often called path-
ogen-associated molecular patterns
[PAMPs]) and elicit pathogen-specific
cellular responses that result in elimi-
nation of intruders as well as, in higher
vertebrates, mobilization of the adap-
tive immune system.
Toll-like receptor (TLR) signaling can
be exemplified by the signal transduc-
tion pathways of the family-founding
member, TLR4. Its signaling cascade
starts with recruitment of a number of
adaptor molecules, which include TNF
receptor-associated factor 6 (TRAF6),
a ubiquitin E3 ligase that activates ef-
fector kinase cascades leading to the
mobilization of downstream transcrip-
tional factors (e.g., AP-1 and NF-kB)
that in turn orchestrate regulation of
immune-response genes. NF-kB is a
key transcriptional factor that regu-
lates all aspects of the innate immunity
response from synthesis of proinflam-Immunity 26matory cytokines, such as IL-1b and
TNFa, to regulation of immune cell
migration and remodeling of tissues
after the successful termination of the
inflammatory response.
Recently, our laboratory has carried
out a systematic effort to identify
miRNAs that play a role in themamma-
lian response to microbial infection
(Taganov et al., 2006). We identified
three miRNAs (miR-146, miR-132,
and miR-155) that are sharply upregu-
lated in response to lipopolysaccha-
ride (LPS) in human monocytic cells.
A detailed survey of miR-146 expres-
sion in response to various microbial
components revealed that an increase
in miR-146 levels is induced by certain
members of the Toll receptor family: It
is triggered by those TLRs that (1) can
sensebacterial rather thanviral PAMPs
and (2) reside on the cell surface. It is
worth noting that miR-146 expression
is also weakly inducible by the proin-
flamatory cytokines, IL-1 and TNF,
whose cognate receptors share some
of their signaling machinery with TLRs.
Mammals encode two copies of
miR146, namely miR146a and
miR146b; the genes are located on
separate chromosomes in the context
of quite unrelated genes but differ in
their mature sequence only by two nu-
cleotides at the 30 end.We have shown
that both loci respond to LPS and de-
termined that induction of expression
ofMIRN146A is NF-kB dependent. In-
terestingly, analysis of expression of
mature miRNA products of these two
genes led us to a surprising finding:
Whereas amounts of mature miR-146a
were increased by LPS, miR-146b ex-
pression remained unchanged, sug-
gesting that this miRNA family has
a rather sophisticated mode of regula-
tion of expression involving more than
one point of control.
A biological role for the miR-146
family is not difficult to suggest be-
cause the list of its conserved pre-
dicted targets is topped by two genes,
IL-1 receptor-associated kinase 1
(IRAK1) and TRAF6, whose involve-
ment in TLR and proinflammatory
cytokine (i.e., IL-1) signaling is well es-
tablished. Indeed, we were able to
show that these two adapters can
potentially be subjects of regulation
by miR-146 through the use of 30, February 2007 ª2007 Elsevier Inc. 135
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reporter assays; we demonstrated a
substantial drop in luciferase activity
when the 30 UTRs of either the IRAK1
or TRAF6 genes was fused down-
stream of the luciferase ORF and
miR-146 was present. Because these
two molecules work in a linear signal-
ing cascade, a cumulative effect of a
drop in their protein expression should
have a substantial impact on IL-1 and
TLR receptor signaling.
Because overactivation of the innate
immunity system can be seriously
detrimental to the organism and in ex-
treme cases can lead to systemic ef-
fects such as septic shock or lead to
local chronic effects such as rheuma-
toid arthritis or inflammatory bowel
disease, the signaling cascades acti-
vating innate immunity are subject to
layers of regulation. We have pro-
posed thatmiR-146 can serve as a reg-
ulator of TLR and cytokine signaling
by acting in a negative feedback loop
to attenuate activation of downstream
genes through posttranscriptional reg-
ulation of expression of the IRAK1 and
TRAF6 proteins.
One can also propose a role for miR-
146 in endotoxin tolerance. It has been
known for decades that exposure to
bacterial products, such as LPS, can
cause desensitization of immune cells
and reduce production of proinflam-
matory cytokines in response to sub-
sequent bacterial challenge. Although
there are multiple theories to explain
this phenomenon, one of the major
mechanisms seems to be blockade
of signaling. A few publications in this
field suggest that reduction in expres-
sion of IRAK1 protein in response to
the first bacterial challenge might be
a reason for the cell’s becoming re-
fractory to the next LPS treatment (Li
et al., 2000; Siedlar et al., 2004). These
authors also noted that although
IRAK1 protein levels fell dramatically
during the induction of endotoxin toler-
ance, its mRNA amounts were not af-
fected, and such a scenario fits the
miRNA mode of action. Of note, miR-
146 is also predicted to exhibit an anti-
viral role because its binding site has
been observed in the genome of the
PFV-1 virus, Dengue virus, Hepatitis
C virus, Influenza B virus, and several
others (Hsu et al., 2007).136 Immunity 26, February 2007 ª2007 EA second LPS-inducible miRNA,
miR-132, identified through our micro-
array studies, has been recently shown
to be a CREB-responsive gene that
regulates neuronal outgrowth in the rat
by controlling the expression of the
GTPase-activating protein p250GAP
(Vo et al., 2005). Because members
of the CREB and ATF family were re-
ported to play a role in LPS signaling
(Gilchrist et al., 2006), it will be interest-
ing to see whether it also mediates the
upregulation of miR-132 expression in
response to endotoxin in monocytes
or whether the activation goes through
the classical inflammation mediator,
NF-kB. Of note, we observed differ-
ences in expression between miR-132
and miR-146 in response to other
immunity-related stimuli, suggesting
different transcriptional or posttran-
scriptional regulation. For example,
miR-132 is highly induced in response
to phorbol-12-myristate-13-acetate,
whereas no response is seen for the
level of mature miR-146 (unpublished
data).
Our latest ‘‘fishing expedition’’ to
identify miRNAs upregulated during
the macrophage antiviral response
netted us a single catch, miR-155. Up-
regulation of miR-155 seems to be
under the control of TLR3 and, to a
lesser extent, the IFNab receptor in
mouse bone-marrow-derived macro-
phages (O’Connell et al., 2007). Al-
though TLR3 induces miR-155 as an
immediate early gene, upregulation
of miR-155 by IFNs is indirect and
requires TNFa autocrine or paracrine
signaling. Thus, we found that miR-
155 is induced by both bacterial (i.e.,
LPS) and viral (i.e., double-stranded
RNA) ligands, suggesting a role for
miR-155 in the regulation of antimicro-
bial defense. Although miR-155 func-
tion under physiological conditions
awaits discovery, its involvement in
the development of B cell malignan-
cies is well documented (reviewed in
[Calin and Croce, 2006]). Therefore,
miR-155 may provide a potential link
between the inflammatory response
and cancer.
The complete scope of miRNA in-
volvement in immunity will probably
take some time to emerge, but it is al-
ready clear that these tiny players can
have a big impact on this complicatedlsevier Inc.and life-sustaining system. Because
miRNAs appear to provide quantitative
regulation of genes, rather than on-off
decisions, they can be seen as fine-
tuning a cell’s responses to external
influences. Although the immune
system developed early in metazoan
evolution, each organism has its own
constellation of pathogens and each
immune system is tuned to that partic-
ular set of challenges. We can specu-
late that the shaping of immune reac-
tions, both in terms of the repertoire
of immune cells and the magnitude
and duration of response to particular
pathogens, is an important function
of miRNAs. Because they regulate
through very short interaction sites
where one or a few base pairs can
play a critical role, they should beeasily
mutable over evolutionary time and
provide for the organism a reservoir of
genetic regulators that can be brought
into play on the same time scale as the
evolution of pathogens. Also, as seen
for miR-146 family, the same regulator
can appear in quite different genomic
contexts and therefore show variance
in expression patterns. As a result, it
might be involved in shaping the re-
sponse to different stimuli.
Although the discovery of miRNAs
has provided us with a key, previously
unappreciated player in orchestrating
the immune response, it is perhaps
not too optimistic to suggest that in
the future, novel strategies for thera-
peutic intervention in immune-related
diseases could be based onmanipula-
tion of miRNA levels.
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